FDA approves Roches Lucentis (ranibizumab injection) for diabetic retinopathy, the leading cause of blindness among working age adults in the United States

21st April 2017 Uncategorised 0

Roche

More: FDA approves Roches Lucentis (ranibizumab injection) for diabetic retinopathy, the leading cause of blindness among working age adults in the United States
Source: MDlinx